The role of clonal communication and heterogeneity in breast cancer

[Background] Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We...

ver descrição completa

Detalhes bibliográficos
Autores: Martín-Pardillos, Ana, Valls Chiva, Ángeles, Bande Vargas, Gemma, Hurtado Blanco, Pablo, Piñeiro Cid, Roberto, Guijarro, Pedro J., Hümmer, Stefan, Bejar Serrano, Eva, Rodriguez-Casanova, Aitor, Díaz-Lagares, Ángel, Castellví, Josep, Miravet-Verde, Samuel, Serrano, Luis, Lluch-Senar, María, Sebastián, Víctor, Bribián, Ana, López-Mascaraque, Laura, López-López, Rafael, Ramón y Cajal, Santiago
Tipo de documento: artigo
Data de publicação:2019
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositório:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/185584
Acesso em linha:http://hdl.handle.net/10261/185584
Access Level:Acceso aberto
Palavra-chave:Tumor
Breast
Cancer
Metastasis
Heterogeneity
Clone
Communication
Cooperation
MDA-MB-231
id ES_cbb6800a8cca945de11b6cd045af9cfd
oai_identifier_str oai:digital.csic.es:10261/185584
network_acronym_str ES
network_name_str España
repository_id_str
spelling The role of clonal communication and heterogeneity in breast cancerMartín-Pardillos, AnaValls Chiva, ÁngelesBande Vargas, GemmaHurtado Blanco, PabloPiñeiro Cid, RobertoGuijarro, Pedro J.Hümmer, StefanBejar Serrano, EvaRodriguez-Casanova, AitorDíaz-Lagares, ÁngelCastellví, JosepMiravet-Verde, SamuelSerrano, LuisLluch-Senar, MaríaSebastián, VíctorBribián, AnaLópez-Mascaraque, LauraLópez-López, RafaelRamón y Cajal, SantiagoTumorBreastCancerMetastasisHeterogeneityCloneCommunicationCooperationMDA-MB-231[Background] Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms underlying the cooperation between different clones.[Methods] We produced clonal cell lines derived from the MDA-MB-231 breast cancer cell line, using the UbC-StarTrack system, which allowed tracking of multiple clones by color: GFP C3, mKO E10 and Sapphire D7. Characterization of these clones was performed by growth rate, cell metabolic activity, wound healing, invasion assays and genetic and epigenetic arrays. Tumorigenicity was tested by orthotopic and intravenous injections. Clonal cooperation was evaluated by medium complementation, co-culture and co-injection assays.[Results] Characterization of these clones in vitro revealed clear genetic and epigenetic differences that affected growth rate, cell metabolic activity, morphology and cytokine expression among cell lines. In vivo, all clonal cell lines were able to form tumors; however, injection of an equal mix of the different clones led to tumors with very few mKO E10 cells. Additionally, the mKO E10 clonal cell line showed a significant inability to form lung metastases. These results confirm that even in stable cell lines heterogeneity is present. In vitro, the complementation of growth medium with medium or exosomes from parental or clonal cell lines increased the growth rate of the other clones. Complementation assays, co-growth and co-injection of mKO E10 and GFP C3 clonal cell lines increased the efficiency of invasion and migration.[Conclusions] These findings support a model where interplay between clones confers aggressiveness, and which may allow identification of the factors involved in cellular communication that could play a role in clonal cooperation and thus represent new targets for preventing tumor progression.SRYC acknowledges support from Fondo de Investigaciones Sanitarias (FIS; PI17/02247 and PI14/01320), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC; CB16/12/00363) and Generalitat de Catalunya (AGAUR; 2017 SGR 1799 and 2014 SGR 1131). AMP is funded by a FP7 Marie Sklodowska-Curie COFUND program under Grant Agreement n° 267128 (INCOMED program). ADL is funded by a “Juan Rodés” contract (JR17/00016) from ISCIII.Peer reviewedBioMed CentralGeneralitat de CatalunyaInstituto de Salud Carlos IIIEuropean CommissionConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2019201920192019info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501http://hdl.handle.net/10261/185584reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/EC/FP7/267128https://doi.org/10.1186/s12885-019-5883-yPublisher's versionSíinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/1855842026-05-22T06:33:51Z
dc.title.none.fl_str_mv The role of clonal communication and heterogeneity in breast cancer
title The role of clonal communication and heterogeneity in breast cancer
spellingShingle The role of clonal communication and heterogeneity in breast cancer
Martín-Pardillos, Ana
Tumor
Breast
Cancer
Metastasis
Heterogeneity
Clone
Communication
Cooperation
MDA-MB-231
title_short The role of clonal communication and heterogeneity in breast cancer
title_full The role of clonal communication and heterogeneity in breast cancer
title_fullStr The role of clonal communication and heterogeneity in breast cancer
title_full_unstemmed The role of clonal communication and heterogeneity in breast cancer
title_sort The role of clonal communication and heterogeneity in breast cancer
dc.creator.none.fl_str_mv Martín-Pardillos, Ana
Valls Chiva, Ángeles
Bande Vargas, Gemma
Hurtado Blanco, Pablo
Piñeiro Cid, Roberto
Guijarro, Pedro J.
Hümmer, Stefan
Bejar Serrano, Eva
Rodriguez-Casanova, Aitor
Díaz-Lagares, Ángel
Castellví, Josep
Miravet-Verde, Samuel
Serrano, Luis
Lluch-Senar, María
Sebastián, Víctor
Bribián, Ana
López-Mascaraque, Laura
López-López, Rafael
Ramón y Cajal, Santiago
author Martín-Pardillos, Ana
author_facet Martín-Pardillos, Ana
Valls Chiva, Ángeles
Bande Vargas, Gemma
Hurtado Blanco, Pablo
Piñeiro Cid, Roberto
Guijarro, Pedro J.
Hümmer, Stefan
Bejar Serrano, Eva
Rodriguez-Casanova, Aitor
Díaz-Lagares, Ángel
Castellví, Josep
Miravet-Verde, Samuel
Serrano, Luis
Lluch-Senar, María
Sebastián, Víctor
Bribián, Ana
López-Mascaraque, Laura
López-López, Rafael
Ramón y Cajal, Santiago
author_role author
author2 Valls Chiva, Ángeles
Bande Vargas, Gemma
Hurtado Blanco, Pablo
Piñeiro Cid, Roberto
Guijarro, Pedro J.
Hümmer, Stefan
Bejar Serrano, Eva
Rodriguez-Casanova, Aitor
Díaz-Lagares, Ángel
Castellví, Josep
Miravet-Verde, Samuel
Serrano, Luis
Lluch-Senar, María
Sebastián, Víctor
Bribián, Ana
López-Mascaraque, Laura
López-López, Rafael
Ramón y Cajal, Santiago
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Generalitat de Catalunya
Instituto de Salud Carlos III
European Commission
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Tumor
Breast
Cancer
Metastasis
Heterogeneity
Clone
Communication
Cooperation
MDA-MB-231
topic Tumor
Breast
Cancer
Metastasis
Heterogeneity
Clone
Communication
Cooperation
MDA-MB-231
description [Background] Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms underlying the cooperation between different clones.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/185584
url http://hdl.handle.net/10261/185584
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/EC/FP7/267128
https://doi.org/10.1186/s12885-019-5883-y
Publisher's version

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419612330786816
score 15,812429